| 1 | questionnaire | 15,946 |
| 2 | quiz | 98 |
| 3 | screener | 92 |
| 4 | goniometer | 58 |
| 5 | proforma | 53 |
| 6 | colorimeter | 19 |
| 7 | questionnaire-revised | 19 |
| 8 | questionnaire-12 | 14 |
| 9 | bref | 12 |
| 10 | profile-14 | 8 |
| 11 | questionaire | 8 |
| 12 | test-6 | 8 |
| 13 | y-1 | 8 |
| 14 | meddietscore | 7 |
| 15 | performa | 6 |
| 16 | psa-cr | 6 |
| 17 | questionnaire-7 | 6 |
| 18 | carboxaldehyde | 5 |
| 19 | minidrink | 5 |
| 20 | 25-cm | 4 |
| 21 | avaleha | 4 |
| 22 | chromometer | 4 |
| 23 | desiccator | 4 |
| 24 | four-country | 4 |
| 25 | questionnaire- | 4 |
| 26 | questionnaire-15 | 4 |
| 27 | questionnaire-20 | 4 |
| 28 | questionnaire-5 | 4 |
| 29 | questionnaire-abbreviated | 4 |
| 30 | rhinotherm | 4 |
| 31 | scale-16 | 4 |
| 32 | single-column | 4 |
| 33 | test™ | 4 |
| 34 | average-pain | 3 |
| 35 | item-11 | 3 |
| 36 | laddermill | 3 |
| 37 | questionnaire-6 | 3 |
| 38 | scale-29 | 3 |
| 39 | self-performance | 3 |
| 40 | sphygmograph | 3 |
| 41 | β=-0.24 | 3 |
| 42 | 10-year-period | 2 |
| 43 | 107-item | 2 |
| 44 | 3-nodal | 2 |
| 45 | 7-page | 2 |
| 46 | 72.69 | 2 |
| 47 | a-scale | 2 |
| 48 | beta-lactamin | 2 |
| 49 | boron-dipyrromethene | 2 |
| 50 | control-task | 2 |
| 51 | data-abstraction | 2 |
| 52 | ettinger | 2 |
| 53 | inventory-student | 2 |
| 54 | metalloprotein | 2 |
| 55 | ministernotomy | 2 |
| 56 | minotransferase | 2 |
| 57 | pre-meeting | 2 |
| 58 | pseudobivalent | 2 |
| 59 | questionnare | 2 |
| 60 | rr=2.49 | 2 |
| 61 | spirogram | 2 |
| 62 | stress-test | 2 |
| 63 | sudorometer | 2 |
| 64 | test-26 | 2 |
| 65 | test-40 | 2 |
| 66 | titanium-mesh | 2 |
| 67 | tool-team | 2 |
| 68 | triamcinolone/demeclocycyline | 2 |
| 69 | turbuhaler™ | 2 |
| 70 | y-6 | 2 |
| 71 | β=1.06 | 2 |
| 72 | 'v'-shaped | 1 |
| 73 | +0.33d | 1 |
| 74 | -758 | 1 |
| 75 | 0-1-2-month | 1 |
| 76 | 0.05-ml | 1 |
| 77 | 0.07-g/dl | 1 |
| 78 | 0.14±0.0c-molc-mol | 1 |
| 79 | 0.17-mmhg | 1 |
| 80 | 0.25-mmol/l | 1 |
| 81 | 0.32-g/m | 1 |
| 82 | 0.43-ml/m | 1 |
| 83 | 0.63-mmhg | 1 |
| 84 | 0.8-day | 1 |
| 85 | 1-o-alkyl-2,3-diacyl-sn-glycerols | 1 |
| 86 | 1.18-fold | 1 |
| 87 | 1.52-fold | 1 |
| 88 | 1.543-fold | 1 |
| 89 | 1.64-fold | 1 |
| 90 | 1.8-unit | 1 |
| 91 | 1.833-fold | 1 |
| 92 | 1.875-fold | 1 |
| 93 | 1.93-fold | 1 |
| 94 | 10-centimorgan | 1 |
| 95 | 10-methacryloyloxydecyl-dihydrogen-phosphate | 1 |
| 96 | 1000-mg·l | 1 |
| 97 | 10volt/meter | 1 |
| 98 | 11.9-point | 1 |
| 99 | 12-3-12- | 1 |
| 100 | 12-millisecond | 1 |
| 101 | 12.01-point | 1 |
| 102 | 1247-kj | 1 |
| 103 | 128.8mm | 1 |
| 104 | 15.3-month | 1 |
| 105 | 15.3-point | 1 |
| 106 | 152-day | 1 |
| 107 | 1536-snp | 1 |
| 108 | 16.5-point | 1 |
| 109 | 2,3-dihydropyridin-4-one | 1 |
| 110 | 2,6-dimethyl-1h-indole-3-carboxamide | 1 |
| 111 | 2-degree-of-freedom | 1 |
| 112 | 2-d·wk | 1 |
| 113 | 2-halo-3-hexylthiophene | 1 |
| 114 | 2-meal | 1 |
| 115 | 2-ml·kg | 1 |
| 116 | 2-nitroimidazole- | 1 |
| 117 | 2-nodal | 1 |
| 118 | 2-trait | 1 |
| 119 | 2.02-fold | 1 |
| 120 | 2.05-point | 1 |
| 121 | 2.1-kj | 1 |
| 122 | 2.30-fold | 1 |
| 123 | 2.57-fold | 1 |
| 124 | 2.7-cm | 1 |
| 125 | 20-edent | 1 |
| 126 | 20-yd | 1 |
| 127 | 217-ml | 1 |
| 128 | 24/28rnp-depleted | 1 |
| 129 | 25-cell/mm | 1 |
| 130 | 25.3-ml/m | 1 |
| 131 | 255-second | 1 |
| 132 | 27.4-fold | 1 |
| 133 | 3'-rhodamine | 1 |
| 134 | 3,543-nucleotide | 1 |
| 135 | 3,9- | 1 |
| 136 | 3-day-course | 1 |
| 137 | 3-diensional | 1 |
| 138 | 3-dimensinoal | 1 |
| 139 | 3-dimenstional | 1 |
| 140 | 3-hy-droxy-picolinate | 1 |
| 141 | 3-keto-5α-steroid-δ | 1 |
| 142 | 3-methoxyphenylcarboxamide | 1 |
| 143 | 3-month- | 1 |
| 144 | 3.18-fold | 1 |
| 145 | 3.2-time | 1 |
| 146 | 3.4-cc | 1 |
| 147 | 3.5-french | 1 |
| 148 | 3.6-kg | 1 |
| 149 | 31-mg/dl | 1 |
| 150 | 31/3/1995-31/12/2001 | 1 |
| 151 | 32-nucleotide | 1 |
| 152 | 35-gauge | 1 |
| 153 | 3x•week | 1 |
| 154 | 4-dibenzocyclooctynol | 1 |
| 155 | 4-nitrobenzo-2-oxa-1,3-diazole | 1 |
| 156 | 4.12-fold | 1 |
| 157 | 4.15-fold | 1 |
| 158 | 4.6-cm | 1 |
| 159 | 4.85-f | 1 |
| 160 | 5'-fluorescein | 1 |
| 161 | 5'-m | 1 |
| 162 | 5-k | 1 |
| 163 | 5-month-period | 1 |
| 164 | 5.4-point | 1 |
| 165 | 50-nmol/l | 1 |
| 166 | 5060-kj | 1 |
| 167 | 53.91g | 1 |
| 168 | 6,7-o- | 1 |
| 169 | 6-domain | 1 |
| 170 | 6-methyl-1h-indazole-3-carboxamide | 1 |
| 171 | 6.00-fold | 1 |
| 172 | 75-second | 1 |
| 173 | 8-ml·kg | 1 |
| 174 | 9-segment | 1 |
| 175 | 9.2-point | 1 |
| 176 | 925-base-pair | 1 |
| 177 | algorithms.there | 1 |
| 178 | baau2 | 1 |
| 179 | bakreshwar | 1 |
| 180 | bathocuproine | 1 |
| 181 | beta=1.010 | 1 |
| 182 | beta=1.611 | 1 |
| 183 | beta=1.911 | 1 |
| 184 | bisphenol-a-glycidyldimethacrylate | 1 |
| 185 | blow-fill-seal | 1 |
| 186 | bmi≥40kg/m | 1 |
| 187 | bmi⩾30kg/m | 1 |
| 188 | bnet | 1 |
| 189 | bolus-plus-continuous-infusion | 1 |
| 190 | boron-10 | 1 |
| 191 | breatlessness | 1 |
| 192 | bric-a-brac/tram-track/broad-complex | 1 |
| 193 | brief-alcohol-intervention | 1 |
| 194 | bsmab/ | 1 |
| 195 | burststimulator | 1 |
| 196 | butadiene-fe | 1 |
| 197 | c-h∙∙∙π | 1 |
| 198 | caltrac | 1 |
| 199 | cannabidiol/delta-9-tetrahydrocannabinol | 1 |
| 200 | cannabinoid-1/2 | 1 |
| 201 | carbonum | 1 |
| 202 | caries-absent-occluded | 1 |
| 203 | caring/task-involving | 1 |
| 204 | case-history | 1 |
| 205 | categories-enjoyment | 1 |
| 206 | ce-electrochemiluminescence | 1 |
| 207 | cece | 1 |
| 208 | ceramic-on-metal | 1 |
| 209 | cese | 1 |
| 210 | char-free | 1 |
| 211 | charge-density-wave | 1 |
| 212 | chinayuan | 1 |
| 213 | chlorhexidine-benzalkonium | 1 |
| 214 | chlorotriisopropoxytitanium | 1 |
| 215 | cholecystokinin-a | 1 |
| 216 | cholesterol-synthesis-enzyme- | 1 |
| 217 | choline-plus-creatine/citrate | 1 |
| 218 | chylomicron-remnant | 1 |
| 219 | co-actor | 1 |
| 220 | co/cso | 1 |
| 221 | cognition-behavior | 1 |
| 222 | combi-tube | 1 |
| 223 | combowire | 1 |
| 224 | control-to-range | 1 |
| 225 | controlledrelease | 1 |
| 226 | control® | 1 |
| 227 | copper-adequate | 1 |
| 228 | corey-bakshi-shibata | 1 |
| 229 | corn/soy-blend | 1 |
| 230 | cross-linked- | 1 |
| 231 | cross-reactant | 1 |
| 232 | cryptomonad | 1 |
| 233 | cu-uid | 1 |
| 234 | cu/cu | 1 |
| 235 | cycloaddition-retro-diels-alder | 1 |
| 236 | cysteinyl-leukotriene-1 | 1 |
| 237 | d=0.57 | 1 |
| 238 | dd-ms | 1 |
| 239 | defries-fulker | 1 |
| 240 | detection/confirmatory | 1 |
| 241 | dibenzocyclooctyne | 1 |
| 242 | diethyl-ether/dichloromethane | 1 |
| 243 | difluoroboradiaza-s-indacene | 1 |
| 244 | digital-image-correlation | 1 |
| 245 | direct-immersion | 1 |
| 246 | disease-independent | 1 |
| 247 | disk-haler | 1 |
| 248 | dissolution/permeation | 1 |
| 249 | distancia | 1 |
| 250 | divinylbenzene/carboxen/polydimethylsiloxane | 1 |
| 251 | double-stair-climbing | 1 |
| 252 | double-strain | 1 |
| 253 | dtdt | 1 |
| 254 | dye-al | 1 |
| 255 | dynamic-balance-training | 1 |
| 256 | estimate=-0.24 | 1 |
| 257 | estimate=-0.37 | 1 |
| 258 | estimate=-0.43 | 1 |
| 259 | estimate=0.19 | 1 |
| 260 | evaluation.we | 1 |
| 261 | fac-znn | 1 |
| 262 | faith-healer | 1 |
| 263 | father/stepfather | 1 |
| 264 | fh···ch₂cl | 1 |
| 265 | fibertec | 1 |
| 266 | filter-rectify-filter | 1 |
| 267 | finite-elements | 1 |
| 268 | first-hitting-time | 1 |
| 269 | fkrp | 1 |
| 270 | fluid-solid-growth | 1 |
| 271 | fluoroenzymeimmunoassay | 1 |
| 272 | focused- | 1 |
| 273 | form-from-motion | 1 |
| 274 | formula-driven | 1 |
| 275 | four-condition | 1 |
| 276 | free-flexible | 1 |
| 277 | fruitbar | 1 |
| 278 | function-centred | 1 |
| 279 | fusarium-contaminated | 1 |
| 280 | fv-puree-based-drink | 1 |
| 281 | galacto-glycerolipid | 1 |
| 282 | gastro-intestinal-transport-system | 1 |
| 283 | gastrointestinal/hepatology | 1 |
| 284 | gif-180 | 1 |
| 285 | gifford-mcmahon | 1 |
| 286 | glass-mug | 1 |
| 287 | glycerinated | 1 |
| 288 | glycerol-3-phosphatase | 1 |
| 289 | glycosyl-phosphatidylinositol | 1 |
| 290 | goose-type | 1 |
| 291 | gradual-weight-reduction | 1 |
| 292 | graft-versus-disease | 1 |
| 293 | graft-versus-tumor/leukemia | 1 |
| 294 | graphene-fullerene | 1 |
| 295 | h-si | 1 |
| 296 | hat-syndrome | 1 |
| 297 | heptafluoropropyl-substituent | 1 |
| 298 | hexa-iodido-tellurate | 1 |
| 299 | hexamidine-chlorhexidine-chlorocresol | 1 |
| 300 | hfhs-high-fat | 1 |
| 301 | high-calorie-expenditure | 1 |
| 302 | high-calorie/high-fat-diet | 1 |
| 303 | high-exercise | 1 |
| 304 | high-monounsaturated-fatty-acid | 1 |
| 305 | high-normal-protein | 1 |
| 306 | high-saturated-fatty-acid | 1 |
| 307 | high-tac | 1 |
| 308 | hyperdopaminergia | 1 |
| 309 | hyperglucidic | 1 |
| 310 | hypermucoviscosity | 1 |
| 311 | hyperproteinaemia | 1 |
| 312 | index-5 | 1 |
| 313 | ktiopo | 1 |
| 314 | landline/telephone | 1 |
| 315 | ldh/pts | 1 |
| 316 | less-than- | 1 |
| 317 | liclo | 1 |
| 318 | lipase-dead | 1 |
| 319 | lipase-esterase | 1 |
| 320 | lisa-nut | 1 |
| 321 | little- | 1 |
| 322 | long-term-care-facility | 1 |
| 323 | low-antigen-dose | 1 |
| 324 | low-genistein | 1 |
| 325 | low-glass-transition-temperature | 1 |
| 326 | low-glycaemic-index | 1 |
| 327 | macria | 1 |
| 328 | magnet-cuff-distance | 1 |
| 329 | magnetic-nanofluid | 1 |
| 330 | maize-ecosystem | 1 |
| 331 | maleimidopropionyl | 1 |
| 332 | mannitol-trehalose-nacl | 1 |
| 333 | measure-diabetes | 1 |
| 334 | mechanical-resuscitation-device | 1 |
| 335 | mechanically- | 1 |
| 336 | mediolateral-oblique | 1 |
| 337 | mercapto-acetyltriglycine | 1 |
| 338 | metaorganism | 1 |
| 339 | micro-cavity | 1 |
| 340 | microbially-fermentable | 1 |
| 341 | micronailtm | 1 |
| 342 | microorganism-binding | 1 |
| 343 | microrna-107 | 1 |
| 344 | microvitreoretinal | 1 |
| 345 | mini-goal | 1 |
| 346 | minifying | 1 |
| 347 | minusheet | 1 |
| 348 | mismatch-negativity | 1 |
| 349 | mixed-response | 1 |
| 350 | moderate-exercise | 1 |
| 351 | module-adult | 1 |
| 352 | monothera-py | 1 |
| 353 | morning-training-group | 1 |
| 354 | mu3fe | 1 |
| 355 | multi-measurements | 1 |
| 356 | multi-vulva | 1 |
| 357 | multidrug-tolerant | 1 |
| 358 | multimedia-supported | 1 |
| 359 | mutely | 1 |
| 360 | myelodysplastic/myeloproliferative | 1 |
| 361 | n-cu | 1 |
| 362 | nacos | 1 |
| 363 | nanohplc-nanoesi | 1 |
| 364 | naturalistic-empirical | 1 |
| 365 | naturlose | 1 |
| 366 | neiguanc | 1 |
| 367 | neurokinin1 | 1 |
| 368 | no-energy | 1 |
| 369 | no-jacket | 1 |
| 370 | no-observed-effect-level | 1 |
| 371 | no-yes | 1 |
| 372 | non-carbohydrate | 1 |
| 373 | non-chlorofluorocarbon | 1 |
| 374 | non-cmr | 1 |
| 375 | non-ipr | 1 |
| 376 | noncolloid | 1 |
| 377 | nonperfusing | 1 |
| 378 | nonwarning | 1 |
| 379 | normal-training-group | 1 |
| 380 | nuclear-bound | 1 |
| 381 | nucleon-nucleon | 1 |
| 382 | nurse-facilitated-cognitive-group | 1 |
| 383 | nversusu-test | 1 |
| 384 | p-value≤10 | 1 |
| 385 | p.tyr278cys | 1 |
| 386 | p45017a1 | 1 |
| 387 | pan-pkc | 1 |
| 388 | para-cf | 1 |
| 389 | partner/child | 1 |
| 390 | pcwallstent | 1 |
| 391 | peg-pcl-peg | 1 |
| 392 | pharmaceutical-equivalent | 1 |
| 393 | pharmaco-epidemiology | 1 |
| 394 | pharmaco-invasive | 1 |
| 395 | pharmacy/clinic | 1 |
| 396 | phospho-t | 1 |
| 397 | photopolymerizing | 1 |
| 398 | phyto-drug | 1 |
| 399 | piezosensor | 1 |
| 400 | polycarbonate-urethane | 1 |
| 401 | polytetrafluoroethene | 1 |
| 402 | polythioester | 1 |
| 403 | post-critical-point | 1 |
| 404 | postal/fax | 1 |
| 405 | pr-1 | 1 |
| 406 | prescription-oriented | 1 |
| 407 | present-on-admission | 1 |
| 408 | pro-catabolic | 1 |
| 409 | probiotic/test | 1 |
| 410 | profile-20e | 1 |
| 411 | profile-49 | 1 |
| 412 | profile-68 | 1 |
| 413 | profile-edent | 1 |
| 414 | protease-inhibitor-modulating-matrix | 1 |
| 415 | protein-free-haemodialisate | 1 |
| 416 | proton-pump-inhibitor | 1 |
| 417 | pseudo-experimental | 1 |
| 418 | pten-pi | 1 |
| 419 | pubmed-search | 1 |
| 420 | pulley-cable | 1 |
| 421 | pvdf-mesh | 1 |
| 422 | pyranoflavonoid | 1 |
| 423 | pyrazine-2- | 1 |
| 424 | qiandu | 1 |
| 425 | quadrupole-quadrupole-time-of-flight | 1 |
| 426 | quarter-mile | 1 |
| 427 | question-3 | 1 |
| 428 | questionare | 1 |
| 429 | questionnair | 1 |
| 430 | questionnaire-cancer | 1 |
| 431 | questionnaire-trip | 1 |
| 432 | questionnaire/itaq | 1 |
| 433 | questionnnaire-18 | 1 |
| 434 | racially-representative | 1 |
| 435 | radial-cephalic | 1 |
| 436 | radio-over-fiber | 1 |
| 437 | rag2 | 1 |
| 438 | recollect/know/no-memory | 1 |
| 439 | red-leafed | 1 |
| 440 | reductase-inhibitors | 1 |
| 441 | regular-chow | 1 |
| 442 | reliable-change-index | 1 |
| 443 | reporter-interpreter-manager-educator | 1 |
| 444 | reverse-d4f | 1 |
| 445 | reward-processing | 1 |
| 446 | rheumatoid-arthritis- | 1 |
| 447 | risk-20 | 1 |
| 448 | rp-18e | 1 |
| 449 | rp-c | 1 |
| 450 | saard-hydroxychloroquine | 1 |
| 451 | scale-parent/child | 1 |
| 452 | self-motivational | 1 |
| 453 | semitendinosus-gracilis-polyester | 1 |
| 454 | sert-knockout | 1 |
| 455 | servosystem | 1 |
| 456 | side-hop | 1 |
| 457 | silicon-d | 1 |
| 458 | silicore | 1 |
| 459 | single-layer-based | 1 |
| 460 | sirna/poly | 1 |
| 461 | six-group | 1 |
| 462 | six-histidine | 1 |
| 463 | sixteen-year | 1 |
| 464 | small-group-discussion | 1 |
| 465 | sncl2/amf/naf | 1 |
| 466 | soil-plant-atmosphere | 1 |
| 467 | somatostatin-analog | 1 |
| 468 | speakerphone | 1 |
| 469 | starch-matrix | 1 |
| 470 | state-administered | 1 |
| 471 | stopband | 1 |
| 472 | streptotoccus | 1 |
| 473 | structural-study | 1 |
| 474 | subdiffusion | 1 |
| 475 | sucad | 1 |
| 476 | summary/abstract | 1 |
| 477 | sunfire™ | 1 |
| 478 | susceptible-infected-susceptible | 1 |
| 479 | susceptible-infectious-recovered-susceptible | 1 |
| 480 | t3/ | 1 |
| 481 | tac/azathioprine | 1 |
| 482 | tantloi | 1 |
| 483 | tapering-group | 1 |
| 484 | tbz-sensitive | 1 |
| 485 | tcm-only | 1 |
| 486 | tearscope-plus | 1 |
| 487 | teca/co | 1 |
| 488 | tetra-ethyl-ammonium | 1 |
| 489 | tetraphenylporphyrin | 1 |
| 490 | tetraspanin-3 | 1 |
| 491 | tetratricopeptide-repeat | 1 |
| 492 | th1-profile | 1 |
| 493 | theozyme | 1 |
| 494 | thermalcycler | 1 |
| 495 | theta/low-beta | 1 |
| 496 | think-pad | 1 |
| 497 | thiotepa-based | 1 |
| 498 | three-centre-four-electron | 1 |
| 499 | three-dimensionalthree | 1 |
| 500 | thy1.2-ip | 1 |
| 501 | thymol-chemotype | 1 |
| 502 | ticagrelor-aspirin | 1 |
| 503 | tissue-micro-array | 1 |
| 504 | tnaa-am-deleted | 1 |
| 505 | tnfr1/traf2/rac1/p47 | 1 |
| 506 | toluene-polyethylene | 1 |
| 507 | top-orthogonal-to-bottom-electrode | 1 |
| 508 | trader | 1 |
| 509 | treated-per-protocol | 1 |
| 510 | trihydroxynaphthalene-hexoside | 1 |
| 511 | triple-plateletpheresis | 1 |
| 512 | trpo | 1 |
| 513 | trypsin-solution | 1 |
| 514 | tungsten/bis | 1 |
| 515 | two-step/self-etching | 1 |
| 516 | tyr/phe-balanced | 1 |
| 517 | u-graft | 1 |
| 518 | u15 | 1 |
| 519 | udp-glucosyltransferase | 1 |
| 520 | units/injection | 1 |
| 521 | usual-salt | 1 |
| 522 | usv | 1 |
| 523 | variable-number-tandem-repeat | 1 |
| 524 | verapamil-sustained-release-led | 1 |
| 525 | vesico-ureteral-reflux | 1 |
| 526 | volume-response | 1 |
| 527 | weight-average-molecular-weight | 1 |
| 528 | well-packed | 1 |
| 529 | widow/widower | 1 |
| 530 | yearling-fed | 1 |
| 531 | zic | 1 |
| 532 | ¥5.0 | 1 |
| 533 | β-starch | 1 |
| 534 | β=-0.10 | 1 |
| 535 | β=0.062 | 1 |
| 536 | β=0.081 | 1 |
| 537 | β=0.084 | 1 |
| 538 | β=0.107 | 1 |
| 539 | β=0.27 | 1 |
| 540 | β=1.12 | 1 |
| 541 | μ1-η | 1 |
| 542 | μ4- | 1 |
| 543 | ≥12/day | 1 |
| 544 | ≥6/day | 1 |
| 1 | 'v'-shaped | 1 |
| 2 | +0.33d | 1 |
| 3 | -758 | 1 |
| 4 | 0-1-2-month | 1 |
| 5 | 0.05-ml | 1 |
| 6 | 0.07-g/dl | 1 |
| 7 | 0.14±0.0c-molc-mol | 1 |
| 8 | 0.17-mmhg | 1 |
| 9 | 0.25-mmol/l | 1 |
| 10 | 0.32-g/m | 1 |
| 11 | 0.43-ml/m | 1 |
| 12 | 0.63-mmhg | 1 |
| 13 | 0.8-day | 1 |
| 14 | 1-o-alkyl-2,3-diacyl-sn-glycerols | 1 |
| 15 | 1.18-fold | 1 |
| 16 | 1.52-fold | 1 |
| 17 | 1.543-fold | 1 |
| 18 | 1.64-fold | 1 |
| 19 | 1.8-unit | 1 |
| 20 | 1.833-fold | 1 |
| 21 | 1.875-fold | 1 |
| 22 | 1.93-fold | 1 |
| 23 | 10-centimorgan | 1 |
| 24 | 10-methacryloyloxydecyl-dihydrogen-phosphate | 1 |
| 25 | 10-year-period | 2 |
| 26 | 1000-mg·l | 1 |
| 27 | 107-item | 2 |
| 28 | 10volt/meter | 1 |
| 29 | 11.9-point | 1 |
| 30 | 12-3-12- | 1 |
| 31 | 12-millisecond | 1 |
| 32 | 12.01-point | 1 |
| 33 | 1247-kj | 1 |
| 34 | 128.8mm | 1 |
| 35 | 15.3-month | 1 |
| 36 | 15.3-point | 1 |
| 37 | 152-day | 1 |
| 38 | 1536-snp | 1 |
| 39 | 16.5-point | 1 |
| 40 | 2,3-dihydropyridin-4-one | 1 |
| 41 | 2,6-dimethyl-1h-indole-3-carboxamide | 1 |
| 42 | 2-degree-of-freedom | 1 |
| 43 | 2-d·wk | 1 |
| 44 | 2-halo-3-hexylthiophene | 1 |
| 45 | 2-meal | 1 |
| 46 | 2-ml·kg | 1 |
| 47 | 2-nitroimidazole- | 1 |
| 48 | 2-nodal | 1 |
| 49 | 2-trait | 1 |
| 50 | 2.02-fold | 1 |
| 51 | 2.05-point | 1 |
| 52 | 2.1-kj | 1 |
| 53 | 2.30-fold | 1 |
| 54 | 2.57-fold | 1 |
| 55 | 2.7-cm | 1 |
| 56 | 20-edent | 1 |
| 57 | 20-yd | 1 |
| 58 | 217-ml | 1 |
| 59 | 24/28rnp-depleted | 1 |
| 60 | 25-cell/mm | 1 |
| 61 | 25-cm | 4 |
| 62 | 25.3-ml/m | 1 |
| 63 | 255-second | 1 |
| 64 | 27.4-fold | 1 |
| 65 | 3'-rhodamine | 1 |
| 66 | 3,543-nucleotide | 1 |
| 67 | 3,9- | 1 |
| 68 | 3-day-course | 1 |
| 69 | 3-diensional | 1 |
| 70 | 3-dimensinoal | 1 |
| 71 | 3-dimenstional | 1 |
| 72 | 3-hy-droxy-picolinate | 1 |
| 73 | 3-keto-5α-steroid-δ | 1 |
| 74 | 3-methoxyphenylcarboxamide | 1 |
| 75 | 3-month- | 1 |
| 76 | 3-nodal | 2 |
| 77 | 3.18-fold | 1 |
| 78 | 3.2-time | 1 |
| 79 | 3.4-cc | 1 |
| 80 | 3.5-french | 1 |
| 81 | 3.6-kg | 1 |
| 82 | 31-mg/dl | 1 |
| 83 | 31/3/1995-31/12/2001 | 1 |
| 84 | 32-nucleotide | 1 |
| 85 | 35-gauge | 1 |
| 86 | 3x•week | 1 |
| 87 | 4-dibenzocyclooctynol | 1 |
| 88 | 4-nitrobenzo-2-oxa-1,3-diazole | 1 |
| 89 | 4.12-fold | 1 |
| 90 | 4.15-fold | 1 |
| 91 | 4.6-cm | 1 |
| 92 | 4.85-f | 1 |
| 93 | 5'-fluorescein | 1 |
| 94 | 5'-m | 1 |
| 95 | 5-k | 1 |
| 96 | 5-month-period | 1 |
| 97 | 5.4-point | 1 |
| 98 | 50-nmol/l | 1 |
| 99 | 5060-kj | 1 |
| 100 | 53.91g | 1 |
| 101 | 6,7-o- | 1 |
| 102 | 6-domain | 1 |
| 103 | 6-methyl-1h-indazole-3-carboxamide | 1 |
| 104 | 6.00-fold | 1 |
| 105 | 7-page | 2 |
| 106 | 72.69 | 2 |
| 107 | 75-second | 1 |
| 108 | 8-ml·kg | 1 |
| 109 | 9-segment | 1 |
| 110 | 9.2-point | 1 |
| 111 | 925-base-pair | 1 |
| 112 | a-scale | 2 |
| 113 | algorithms.there | 1 |
| 114 | avaleha | 4 |
| 115 | average-pain | 3 |
| 116 | baau2 | 1 |
| 117 | bakreshwar | 1 |
| 118 | bathocuproine | 1 |
| 119 | beta-lactamin | 2 |
| 120 | beta=1.010 | 1 |
| 121 | beta=1.611 | 1 |
| 122 | beta=1.911 | 1 |
| 123 | bisphenol-a-glycidyldimethacrylate | 1 |
| 124 | blow-fill-seal | 1 |
| 125 | bmi≥40kg/m | 1 |
| 126 | bmi⩾30kg/m | 1 |
| 127 | bnet | 1 |
| 128 | bolus-plus-continuous-infusion | 1 |
| 129 | boron-10 | 1 |
| 130 | boron-dipyrromethene | 2 |
| 131 | breatlessness | 1 |
| 132 | bref | 12 |
| 133 | bric-a-brac/tram-track/broad-complex | 1 |
| 134 | brief-alcohol-intervention | 1 |
| 135 | bsmab/ | 1 |
| 136 | burststimulator | 1 |
| 137 | butadiene-fe | 1 |
| 138 | c-h∙∙∙π | 1 |
| 139 | caltrac | 1 |
| 140 | cannabidiol/delta-9-tetrahydrocannabinol | 1 |
| 141 | cannabinoid-1/2 | 1 |
| 142 | carbonum | 1 |
| 143 | carboxaldehyde | 5 |
| 144 | caries-absent-occluded | 1 |
| 145 | caring/task-involving | 1 |
| 146 | case-history | 1 |
| 147 | categories-enjoyment | 1 |
| 148 | ce-electrochemiluminescence | 1 |
| 149 | cece | 1 |
| 150 | ceramic-on-metal | 1 |
| 151 | cese | 1 |
| 152 | char-free | 1 |
| 153 | charge-density-wave | 1 |
| 154 | chinayuan | 1 |
| 155 | chlorhexidine-benzalkonium | 1 |
| 156 | chlorotriisopropoxytitanium | 1 |
| 157 | cholecystokinin-a | 1 |
| 158 | cholesterol-synthesis-enzyme- | 1 |
| 159 | choline-plus-creatine/citrate | 1 |
| 160 | chromometer | 4 |
| 161 | chylomicron-remnant | 1 |
| 162 | co-actor | 1 |
| 163 | co/cso | 1 |
| 164 | cognition-behavior | 1 |
| 165 | colorimeter | 19 |
| 166 | combi-tube | 1 |
| 167 | combowire | 1 |
| 168 | control-task | 2 |
| 169 | control-to-range | 1 |
| 170 | controlledrelease | 1 |
| 171 | control® | 1 |
| 172 | copper-adequate | 1 |
| 173 | corey-bakshi-shibata | 1 |
| 174 | corn/soy-blend | 1 |
| 175 | cross-linked- | 1 |
| 176 | cross-reactant | 1 |
| 177 | cryptomonad | 1 |
| 178 | cu-uid | 1 |
| 179 | cu/cu | 1 |
| 180 | cycloaddition-retro-diels-alder | 1 |
| 181 | cysteinyl-leukotriene-1 | 1 |
| 182 | d=0.57 | 1 |
| 183 | data-abstraction | 2 |
| 184 | dd-ms | 1 |
| 185 | defries-fulker | 1 |
| 186 | desiccator | 4 |
| 187 | detection/confirmatory | 1 |
| 188 | dibenzocyclooctyne | 1 |
| 189 | diethyl-ether/dichloromethane | 1 |
| 190 | difluoroboradiaza-s-indacene | 1 |
| 191 | digital-image-correlation | 1 |
| 192 | direct-immersion | 1 |
| 193 | disease-independent | 1 |
| 194 | disk-haler | 1 |
| 195 | dissolution/permeation | 1 |
| 196 | distancia | 1 |
| 197 | divinylbenzene/carboxen/polydimethylsiloxane | 1 |
| 198 | double-stair-climbing | 1 |
| 199 | double-strain | 1 |
| 200 | dtdt | 1 |
| 201 | dye-al | 1 |
| 202 | dynamic-balance-training | 1 |
| 203 | estimate=-0.24 | 1 |
| 204 | estimate=-0.37 | 1 |
| 205 | estimate=-0.43 | 1 |
| 206 | estimate=0.19 | 1 |
| 207 | ettinger | 2 |
| 208 | evaluation.we | 1 |
| 209 | fac-znn | 1 |
| 210 | faith-healer | 1 |
| 211 | father/stepfather | 1 |
| 212 | fh···ch₂cl | 1 |
| 213 | fibertec | 1 |
| 214 | filter-rectify-filter | 1 |
| 215 | finite-elements | 1 |
| 216 | first-hitting-time | 1 |
| 217 | fkrp | 1 |
| 218 | fluid-solid-growth | 1 |
| 219 | fluoroenzymeimmunoassay | 1 |
| 220 | focused- | 1 |
| 221 | form-from-motion | 1 |
| 222 | formula-driven | 1 |
| 223 | four-condition | 1 |
| 224 | four-country | 4 |
| 225 | free-flexible | 1 |
| 226 | fruitbar | 1 |
| 227 | function-centred | 1 |
| 228 | fusarium-contaminated | 1 |
| 229 | fv-puree-based-drink | 1 |
| 230 | galacto-glycerolipid | 1 |
| 231 | gastro-intestinal-transport-system | 1 |
| 232 | gastrointestinal/hepatology | 1 |
| 233 | gif-180 | 1 |
| 234 | gifford-mcmahon | 1 |
| 235 | glass-mug | 1 |
| 236 | glycerinated | 1 |
| 237 | glycerol-3-phosphatase | 1 |
| 238 | glycosyl-phosphatidylinositol | 1 |
| 239 | goniometer | 58 |
| 240 | goose-type | 1 |
| 241 | gradual-weight-reduction | 1 |
| 242 | graft-versus-disease | 1 |
| 243 | graft-versus-tumor/leukemia | 1 |
| 244 | graphene-fullerene | 1 |
| 245 | h-si | 1 |
| 246 | hat-syndrome | 1 |
| 247 | heptafluoropropyl-substituent | 1 |
| 248 | hexa-iodido-tellurate | 1 |
| 249 | hexamidine-chlorhexidine-chlorocresol | 1 |
| 250 | hfhs-high-fat | 1 |
| 251 | high-calorie-expenditure | 1 |
| 252 | high-calorie/high-fat-diet | 1 |
| 253 | high-exercise | 1 |
| 254 | high-monounsaturated-fatty-acid | 1 |
| 255 | high-normal-protein | 1 |
| 256 | high-saturated-fatty-acid | 1 |
| 257 | high-tac | 1 |
| 258 | hyperdopaminergia | 1 |
| 259 | hyperglucidic | 1 |
| 260 | hypermucoviscosity | 1 |
| 261 | hyperproteinaemia | 1 |
| 262 | index-5 | 1 |
| 263 | inventory-student | 2 |
| 264 | item-11 | 3 |
| 265 | ktiopo | 1 |
| 266 | laddermill | 3 |
| 267 | landline/telephone | 1 |
| 268 | ldh/pts | 1 |
| 269 | less-than- | 1 |
| 270 | liclo | 1 |
| 271 | lipase-dead | 1 |
| 272 | lipase-esterase | 1 |
| 273 | lisa-nut | 1 |
| 274 | little- | 1 |
| 275 | long-term-care-facility | 1 |
| 276 | low-antigen-dose | 1 |
| 277 | low-genistein | 1 |
| 278 | low-glass-transition-temperature | 1 |
| 279 | low-glycaemic-index | 1 |
| 280 | macria | 1 |
| 281 | magnet-cuff-distance | 1 |
| 282 | magnetic-nanofluid | 1 |
| 283 | maize-ecosystem | 1 |
| 284 | maleimidopropionyl | 1 |
| 285 | mannitol-trehalose-nacl | 1 |
| 286 | measure-diabetes | 1 |
| 287 | mechanical-resuscitation-device | 1 |
| 288 | mechanically- | 1 |
| 289 | meddietscore | 7 |
| 290 | mediolateral-oblique | 1 |
| 291 | mercapto-acetyltriglycine | 1 |
| 292 | metalloprotein | 2 |
| 293 | metaorganism | 1 |
| 294 | micro-cavity | 1 |
| 295 | microbially-fermentable | 1 |
| 296 | micronailtm | 1 |
| 297 | microorganism-binding | 1 |
| 298 | microrna-107 | 1 |
| 299 | microvitreoretinal | 1 |
| 300 | mini-goal | 1 |
| 301 | minidrink | 5 |
| 302 | minifying | 1 |
| 303 | ministernotomy | 2 |
| 304 | minotransferase | 2 |
| 305 | minusheet | 1 |
| 306 | mismatch-negativity | 1 |
| 307 | mixed-response | 1 |
| 308 | moderate-exercise | 1 |
| 309 | module-adult | 1 |
| 310 | monothera-py | 1 |
| 311 | morning-training-group | 1 |
| 312 | mu3fe | 1 |
| 313 | multi-measurements | 1 |
| 314 | multi-vulva | 1 |
| 315 | multidrug-tolerant | 1 |
| 316 | multimedia-supported | 1 |
| 317 | mutely | 1 |
| 318 | myelodysplastic/myeloproliferative | 1 |
| 319 | n-cu | 1 |
| 320 | nacos | 1 |
| 321 | nanohplc-nanoesi | 1 |
| 322 | naturalistic-empirical | 1 |
| 323 | naturlose | 1 |
| 324 | neiguanc | 1 |
| 325 | neurokinin1 | 1 |
| 326 | no-energy | 1 |
| 327 | no-jacket | 1 |
| 328 | no-observed-effect-level | 1 |
| 329 | no-yes | 1 |
| 330 | non-carbohydrate | 1 |
| 331 | non-chlorofluorocarbon | 1 |
| 332 | non-cmr | 1 |
| 333 | non-ipr | 1 |
| 334 | noncolloid | 1 |
| 335 | nonperfusing | 1 |
| 336 | nonwarning | 1 |
| 337 | normal-training-group | 1 |
| 338 | nuclear-bound | 1 |
| 339 | nucleon-nucleon | 1 |
| 340 | nurse-facilitated-cognitive-group | 1 |
| 341 | nversusu-test | 1 |
| 342 | p-value≤10 | 1 |
| 343 | p.tyr278cys | 1 |
| 344 | p45017a1 | 1 |
| 345 | pan-pkc | 1 |
| 346 | para-cf | 1 |
| 347 | partner/child | 1 |
| 348 | pcwallstent | 1 |
| 349 | peg-pcl-peg | 1 |
| 350 | performa | 6 |
| 351 | pharmaceutical-equivalent | 1 |
| 352 | pharmaco-epidemiology | 1 |
| 353 | pharmaco-invasive | 1 |
| 354 | pharmacy/clinic | 1 |
| 355 | phospho-t | 1 |
| 356 | photopolymerizing | 1 |
| 357 | phyto-drug | 1 |
| 358 | piezosensor | 1 |
| 359 | polycarbonate-urethane | 1 |
| 360 | polytetrafluoroethene | 1 |
| 361 | polythioester | 1 |
| 362 | post-critical-point | 1 |
| 363 | postal/fax | 1 |
| 364 | pr-1 | 1 |
| 365 | pre-meeting | 2 |
| 366 | prescription-oriented | 1 |
| 367 | present-on-admission | 1 |
| 368 | pro-catabolic | 1 |
| 369 | probiotic/test | 1 |
| 370 | profile-14 | 8 |
| 371 | profile-20e | 1 |
| 372 | profile-49 | 1 |
| 373 | profile-68 | 1 |
| 374 | profile-edent | 1 |
| 375 | proforma | 53 |
| 376 | protease-inhibitor-modulating-matrix | 1 |
| 377 | protein-free-haemodialisate | 1 |
| 378 | proton-pump-inhibitor | 1 |
| 379 | psa-cr | 6 |
| 380 | pseudo-experimental | 1 |
| 381 | pseudobivalent | 2 |
| 382 | pten-pi | 1 |
| 383 | pubmed-search | 1 |
| 384 | pulley-cable | 1 |
| 385 | pvdf-mesh | 1 |
| 386 | pyranoflavonoid | 1 |
| 387 | pyrazine-2- | 1 |
| 388 | qiandu | 1 |
| 389 | quadrupole-quadrupole-time-of-flight | 1 |
| 390 | quarter-mile | 1 |
| 391 | question-3 | 1 |
| 392 | questionaire | 8 |
| 393 | questionare | 1 |
| 394 | questionnair | 1 |
| 395 | questionnaire | 15,946 |
| 396 | questionnaire- | 4 |
| 397 | questionnaire-12 | 14 |
| 398 | questionnaire-15 | 4 |
| 399 | questionnaire-20 | 4 |
| 400 | questionnaire-5 | 4 |
| 401 | questionnaire-6 | 3 |
| 402 | questionnaire-7 | 6 |
| 403 | questionnaire-abbreviated | 4 |
| 404 | questionnaire-cancer | 1 |
| 405 | questionnaire-revised | 19 |
| 406 | questionnaire-trip | 1 |
| 407 | questionnaire/itaq | 1 |
| 408 | questionnare | 2 |
| 409 | questionnnaire-18 | 1 |
| 410 | quiz | 98 |
| 411 | racially-representative | 1 |
| 412 | radial-cephalic | 1 |
| 413 | radio-over-fiber | 1 |
| 414 | rag2 | 1 |
| 415 | recollect/know/no-memory | 1 |
| 416 | red-leafed | 1 |
| 417 | reductase-inhibitors | 1 |
| 418 | regular-chow | 1 |
| 419 | reliable-change-index | 1 |
| 420 | reporter-interpreter-manager-educator | 1 |
| 421 | reverse-d4f | 1 |
| 422 | reward-processing | 1 |
| 423 | rheumatoid-arthritis- | 1 |
| 424 | rhinotherm | 4 |
| 425 | risk-20 | 1 |
| 426 | rp-18e | 1 |
| 427 | rp-c | 1 |
| 428 | rr=2.49 | 2 |
| 429 | saard-hydroxychloroquine | 1 |
| 430 | scale-16 | 4 |
| 431 | scale-29 | 3 |
| 432 | scale-parent/child | 1 |
| 433 | screener | 92 |
| 434 | self-motivational | 1 |
| 435 | self-performance | 3 |
| 436 | semitendinosus-gracilis-polyester | 1 |
| 437 | sert-knockout | 1 |
| 438 | servosystem | 1 |
| 439 | side-hop | 1 |
| 440 | silicon-d | 1 |
| 441 | silicore | 1 |
| 442 | single-column | 4 |
| 443 | single-layer-based | 1 |
| 444 | sirna/poly | 1 |
| 445 | six-group | 1 |
| 446 | six-histidine | 1 |
| 447 | sixteen-year | 1 |
| 448 | small-group-discussion | 1 |
| 449 | sncl2/amf/naf | 1 |
| 450 | soil-plant-atmosphere | 1 |
| 451 | somatostatin-analog | 1 |
| 452 | speakerphone | 1 |
| 453 | sphygmograph | 3 |
| 454 | spirogram | 2 |
| 455 | starch-matrix | 1 |
| 456 | state-administered | 1 |
| 457 | stopband | 1 |
| 458 | streptotoccus | 1 |
| 459 | stress-test | 2 |
| 460 | structural-study | 1 |
| 461 | subdiffusion | 1 |
| 462 | sucad | 1 |
| 463 | sudorometer | 2 |
| 464 | summary/abstract | 1 |
| 465 | sunfire™ | 1 |
| 466 | susceptible-infected-susceptible | 1 |
| 467 | susceptible-infectious-recovered-susceptible | 1 |
| 468 | t3/ | 1 |
| 469 | tac/azathioprine | 1 |
| 470 | tantloi | 1 |
| 471 | tapering-group | 1 |
| 472 | tbz-sensitive | 1 |
| 473 | tcm-only | 1 |
| 474 | tearscope-plus | 1 |
| 475 | teca/co | 1 |
| 476 | test-26 | 2 |
| 477 | test-40 | 2 |
| 478 | test-6 | 8 |
| 479 | test™ | 4 |
| 480 | tetra-ethyl-ammonium | 1 |
| 481 | tetraphenylporphyrin | 1 |
| 482 | tetraspanin-3 | 1 |
| 483 | tetratricopeptide-repeat | 1 |
| 484 | th1-profile | 1 |
| 485 | theozyme | 1 |
| 486 | thermalcycler | 1 |
| 487 | theta/low-beta | 1 |
| 488 | think-pad | 1 |
| 489 | thiotepa-based | 1 |
| 490 | three-centre-four-electron | 1 |
| 491 | three-dimensionalthree | 1 |
| 492 | thy1.2-ip | 1 |
| 493 | thymol-chemotype | 1 |
| 494 | ticagrelor-aspirin | 1 |
| 495 | tissue-micro-array | 1 |
| 496 | titanium-mesh | 2 |
| 497 | tnaa-am-deleted | 1 |
| 498 | tnfr1/traf2/rac1/p47 | 1 |
| 499 | toluene-polyethylene | 1 |
| 500 | tool-team | 2 |
| 501 | top-orthogonal-to-bottom-electrode | 1 |
| 502 | trader | 1 |
| 503 | treated-per-protocol | 1 |
| 504 | triamcinolone/demeclocycyline | 2 |
| 505 | trihydroxynaphthalene-hexoside | 1 |
| 506 | triple-plateletpheresis | 1 |
| 507 | trpo | 1 |
| 508 | trypsin-solution | 1 |
| 509 | tungsten/bis | 1 |
| 510 | turbuhaler™ | 2 |
| 511 | two-step/self-etching | 1 |
| 512 | tyr/phe-balanced | 1 |
| 513 | u-graft | 1 |
| 514 | u15 | 1 |
| 515 | udp-glucosyltransferase | 1 |
| 516 | units/injection | 1 |
| 517 | usual-salt | 1 |
| 518 | usv | 1 |
| 519 | variable-number-tandem-repeat | 1 |
| 520 | verapamil-sustained-release-led | 1 |
| 521 | vesico-ureteral-reflux | 1 |
| 522 | volume-response | 1 |
| 523 | weight-average-molecular-weight | 1 |
| 524 | well-packed | 1 |
| 525 | widow/widower | 1 |
| 526 | y-1 | 8 |
| 527 | y-6 | 2 |
| 528 | yearling-fed | 1 |
| 529 | zic | 1 |
| 530 | ¥5.0 | 1 |
| 531 | β-starch | 1 |
| 532 | β=-0.10 | 1 |
| 533 | β=-0.24 | 3 |
| 534 | β=0.062 | 1 |
| 535 | β=0.081 | 1 |
| 536 | β=0.084 | 1 |
| 537 | β=0.107 | 1 |
| 538 | β=0.27 | 1 |
| 539 | β=1.06 | 2 |
| 540 | β=1.12 | 1 |
| 541 | μ1-η | 1 |
| 542 | μ4- | 1 |
| 543 | ≥12/day | 1 |
| 544 | ≥6/day | 1 |
| 1 | pyrazine-2- | 1 |
| 2 | 12-3-12- | 1 |
| 3 | μ4- | 1 |
| 4 | 3,9- | 1 |
| 5 | cross-linked- | 1 |
| 6 | focused- | 1 |
| 7 | 2-nitroimidazole- | 1 |
| 8 | little- | 1 |
| 9 | cholesterol-synthesis-enzyme- | 1 |
| 10 | questionnaire- | 4 |
| 11 | 3-month- | 1 |
| 12 | less-than- | 1 |
| 13 | 6,7-o- | 1 |
| 14 | rheumatoid-arthritis- | 1 |
| 15 | mechanically- | 1 |
| 16 | t3/ | 1 |
| 17 | bsmab/ | 1 |
| 18 | ¥5.0 | 1 |
| 19 | boron-10 | 1 |
| 20 | β=-0.10 | 1 |
| 21 | beta=1.010 | 1 |
| 22 | p-value≤10 | 1 |
| 23 | questionnaire-20 | 4 |
| 24 | risk-20 | 1 |
| 25 | test-40 | 2 |
| 26 | gif-180 | 1 |
| 27 | cysteinyl-leukotriene-1 | 1 |
| 28 | pr-1 | 1 |
| 29 | y-1 | 8 |
| 30 | 31/3/1995-31/12/2001 | 1 |
| 31 | item-11 | 3 |
| 32 | beta=1.611 | 1 |
| 33 | beta=1.911 | 1 |
| 34 | β=0.081 | 1 |
| 35 | p45017a1 | 1 |
| 36 | neurokinin1 | 1 |
| 37 | cannabinoid-1/2 | 1 |
| 38 | questionnaire-12 | 14 |
| 39 | β=1.12 | 1 |
| 40 | β=0.062 | 1 |
| 41 | rag2 | 1 |
| 42 | baau2 | 1 |
| 43 | tetraspanin-3 | 1 |
| 44 | question-3 | 1 |
| 45 | estimate=-0.43 | 1 |
| 46 | profile-14 | 8 |
| 47 | estimate=-0.24 | 1 |
| 48 | β=-0.24 | 3 |
| 49 | β=0.084 | 1 |
| 50 | questionnaire-5 | 4 |
| 51 | index-5 | 1 |
| 52 | questionnaire-15 | 4 |
| 53 | u15 | 1 |
| 54 | questionnaire-6 | 3 |
| 55 | test-6 | 8 |
| 56 | y-6 | 2 |
| 57 | β=1.06 | 2 |
| 58 | scale-16 | 4 |
| 59 | test-26 | 2 |
| 60 | questionnaire-7 | 6 |
| 61 | microrna-107 | 1 |
| 62 | β=0.107 | 1 |
| 63 | β=0.27 | 1 |
| 64 | estimate=-0.37 | 1 |
| 65 | tnfr1/traf2/rac1/p47 | 1 |
| 66 | d=0.57 | 1 |
| 67 | questionnnaire-18 | 1 |
| 68 | -758 | 1 |
| 69 | profile-68 | 1 |
| 70 | estimate=0.19 | 1 |
| 71 | scale-29 | 3 |
| 72 | profile-49 | 1 |
| 73 | rr=2.49 | 2 |
| 74 | 72.69 | 2 |
| 75 | cholecystokinin-a | 1 |
| 76 | avaleha | 4 |
| 77 | distancia | 1 |
| 78 | hyperdopaminergia | 1 |
| 79 | hyperproteinaemia | 1 |
| 80 | graft-versus-tumor/leukemia | 1 |
| 81 | macria | 1 |
| 82 | proforma | 53 |
| 83 | performa | 6 |
| 84 | corey-bakshi-shibata | 1 |
| 85 | theta/low-beta | 1 |
| 86 | multi-vulva | 1 |
| 87 | rp-c | 1 |
| 88 | caltrac | 1 |
| 89 | high-tac | 1 |
| 90 | 3.4-cc | 1 |
| 91 | fibertec | 1 |
| 92 | hyperglucidic | 1 |
| 93 | radial-cephalic | 1 |
| 94 | pro-catabolic | 1 |
| 95 | pharmacy/clinic | 1 |
| 96 | zic | 1 |
| 97 | pan-pkc | 1 |
| 98 | neiguanc | 1 |
| 99 | silicon-d | 1 |
| 100 | +0.33d | 1 |
| 101 | sucad | 1 |
| 102 | lipase-dead | 1 |
| 103 | cryptomonad | 1 |
| 104 | think-pad | 1 |
| 105 | tyr/phe-balanced | 1 |
| 106 | caries-absent-occluded | 1 |
| 107 | yearling-fed | 1 |
| 108 | red-leafed | 1 |
| 109 | well-packed | 1 |
| 110 | verapamil-sustained-release-led | 1 |
| 111 | 'v'-shaped | 1 |
| 112 | state-administered | 1 |
| 113 | function-centred | 1 |
| 114 | thiotepa-based | 1 |
| 115 | single-layer-based | 1 |
| 116 | questionnaire-revised | 19 |
| 117 | questionnaire-abbreviated | 4 |
| 118 | fusarium-contaminated | 1 |
| 119 | glycerinated | 1 |
| 120 | tnaa-am-deleted | 1 |
| 121 | 24/28rnp-depleted | 1 |
| 122 | prescription-oriented | 1 |
| 123 | multimedia-supported | 1 |
| 124 | high-saturated-fatty-acid | 1 |
| 125 | high-monounsaturated-fatty-acid | 1 |
| 126 | noncolloid | 1 |
| 127 | pyranoflavonoid | 1 |
| 128 | galacto-glycerolipid | 1 |
| 129 | cu-uid | 1 |
| 130 | magnetic-nanofluid | 1 |
| 131 | partner/child | 1 |
| 132 | scale-parent/child | 1 |
| 133 | 6.00-fold | 1 |
| 134 | 2.30-fold | 1 |
| 135 | 2.02-fold | 1 |
| 136 | 4.12-fold | 1 |
| 137 | 1.52-fold | 1 |
| 138 | 1.833-fold | 1 |
| 139 | 1.543-fold | 1 |
| 140 | 1.93-fold | 1 |
| 141 | 27.4-fold | 1 |
| 142 | 1.64-fold | 1 |
| 143 | 4.15-fold | 1 |
| 144 | 1.875-fold | 1 |
| 145 | 2.57-fold | 1 |
| 146 | 1.18-fold | 1 |
| 147 | 3.18-fold | 1 |
| 148 | stopband | 1 |
| 149 | corn/soy-blend | 1 |
| 150 | 255-second | 1 |
| 151 | 75-second | 1 |
| 152 | 12-millisecond | 1 |
| 153 | nuclear-bound | 1 |
| 154 | 5-month-period | 1 |
| 155 | 10-year-period | 2 |
| 156 | 20-yd | 1 |
| 157 | profile-20e | 1 |
| 158 | rp-18e | 1 |
| 159 | combi-tube | 1 |
| 160 | cece | 1 |
| 161 | mechanical-resuscitation-device | 1 |
| 162 | self-performance | 3 |
| 163 | magnet-cuff-distance | 1 |
| 164 | ce-electrochemiluminescence | 1 |
| 165 | 2,6-dimethyl-1h-indole-3-carboxamide | 1 |
| 166 | 6-methyl-1h-indazole-3-carboxamide | 1 |
| 167 | 3-methoxyphenylcarboxamide | 1 |
| 168 | trihydroxynaphthalene-hexoside | 1 |
| 169 | 32-nucleotide | 1 |
| 170 | 3,543-nucleotide | 1 |
| 171 | top-orthogonal-to-bottom-electrode | 1 |
| 172 | carboxaldehyde | 5 |
| 173 | char-free | 1 |
| 174 | three-dimensionalthree | 1 |
| 175 | butadiene-fe | 1 |
| 176 | mu3fe | 1 |
| 177 | 7-page | 2 |
| 178 | control-to-range | 1 |
| 179 | 35-gauge | 1 |
| 180 | a-scale | 2 |
| 181 | pulley-cable | 1 |
| 182 | microbially-fermentable | 1 |
| 183 | susceptible-infectious-recovered-susceptible | 1 |
| 184 | susceptible-infected-susceptible | 1 |
| 185 | free-flexible | 1 |
| 186 | th1-profile | 1 |
| 187 | quarter-mile | 1 |
| 188 | 4-nitrobenzo-2-oxa-1,3-diazole | 1 |
| 189 | 3.2-time | 1 |
| 190 | first-hitting-time | 1 |
| 191 | hat-syndrome | 1 |
| 192 | theozyme | 1 |
| 193 | diethyl-ether/dichloromethane | 1 |
| 194 | polycarbonate-urethane | 1 |
| 195 | divinylbenzene/carboxen/polydimethylsiloxane | 1 |
| 196 | difluoroboradiaza-s-indacene | 1 |
| 197 | 2-halo-3-hexylthiophene | 1 |
| 198 | boron-dipyrromethene | 2 |
| 199 | polytetrafluoroethene | 1 |
| 200 | toluene-polyethylene | 1 |
| 201 | graphene-fullerene | 1 |
| 202 | mercapto-acetyltriglycine | 1 |
| 203 | six-histidine | 1 |
| 204 | triamcinolone/demeclocycyline | 2 |
| 205 | 3'-rhodamine | 1 |
| 206 | bathocuproine | 1 |
| 207 | tac/azathioprine | 1 |
| 208 | saard-hydroxychloroquine | 1 |
| 209 | 2,3-dihydropyridin-4-one | 1 |
| 210 | landline/telephone | 1 |
| 211 | speakerphone | 1 |
| 212 | dibenzocyclooctyne | 1 |
| 213 | goose-type | 1 |
| 214 | thymol-chemotype | 1 |
| 215 | questionnare | 2 |
| 216 | questionare | 1 |
| 217 | soil-plant-atmosphere | 1 |
| 218 | algorithms.there | 1 |
| 219 | questionnaire | 15,946 |
| 220 | questionaire | 8 |
| 221 | combowire | 1 |
| 222 | silicore | 1 |
| 223 | meddietscore | 7 |
| 224 | low-glass-transition-temperature | 1 |
| 225 | high-calorie-expenditure | 1 |
| 226 | controlledrelease | 1 |
| 227 | graft-versus-disease | 1 |
| 228 | udp-glucosyltransferase | 1 |
| 229 | minotransferase | 2 |
| 230 | lipase-esterase | 1 |
| 231 | glycerol-3-phosphatase | 1 |
| 232 | cese | 1 |
| 233 | moderate-exercise | 1 |
| 234 | high-exercise | 1 |
| 235 | mixed-response | 1 |
| 236 | volume-response | 1 |
| 237 | low-antigen-dose | 1 |
| 238 | naturlose | 1 |
| 239 | 3-day-course | 1 |
| 240 | 10-methacryloyloxydecyl-dihydrogen-phosphate | 1 |
| 241 | bisphenol-a-glycidyldimethacrylate | 1 |
| 242 | 3-hy-droxy-picolinate | 1 |
| 243 | non-carbohydrate | 1 |
| 244 | choline-plus-creatine/citrate | 1 |
| 245 | hexa-iodido-tellurate | 1 |
| 246 | protein-free-haemodialisate | 1 |
| 247 | copper-adequate | 1 |
| 248 | mediolateral-oblique | 1 |
| 249 | charge-density-wave | 1 |
| 250 | pharmaco-invasive | 1 |
| 251 | myelodysplastic/myeloproliferative | 1 |
| 252 | racially-representative | 1 |
| 253 | tbz-sensitive | 1 |
| 254 | evaluation.we | 1 |
| 255 | 4.85-f | 1 |
| 256 | reverse-d4f | 1 |
| 257 | sncl2/amf/naf | 1 |
| 258 | para-cf | 1 |
| 259 | bref | 12 |
| 260 | 53.91g | 1 |
| 261 | peg-pcl-peg | 1 |
| 262 | 0.63-mmhg | 1 |
| 263 | 0.17-mmhg | 1 |
| 264 | 3.6-kg | 1 |
| 265 | 2-ml·kg | 1 |
| 266 | 8-ml·kg | 1 |
| 267 | double-stair-climbing | 1 |
| 268 | microorganism-binding | 1 |
| 269 | two-step/self-etching | 1 |
| 270 | dynamic-balance-training | 1 |
| 271 | nonwarning | 1 |
| 272 | reward-processing | 1 |
| 273 | nonperfusing | 1 |
| 274 | pre-meeting | 2 |
| 275 | caring/task-involving | 1 |
| 276 | minifying | 1 |
| 277 | photopolymerizing | 1 |
| 278 | somatostatin-analog | 1 |
| 279 | glass-mug | 1 |
| 280 | phyto-drug | 1 |
| 281 | 3.5-french | 1 |
| 282 | pubmed-search | 1 |
| 283 | β-starch | 1 |
| 284 | sphygmograph | 3 |
| 285 | pvdf-mesh | 1 |
| 286 | titanium-mesh | 2 |
| 287 | 0-1-2-month | 1 |
| 288 | 15.3-month | 1 |
| 289 | fluid-solid-growth | 1 |
| 290 | tantloi | 1 |
| 291 | pten-pi | 1 |
| 292 | h-si | 1 |
| 293 | nanohplc-nanoesi | 1 |
| 294 | 5060-kj | 1 |
| 295 | 2.1-kj | 1 |
| 296 | 1247-kj | 1 |
| 297 | 5-k | 1 |
| 298 | 3x•week | 1 |
| 299 | fv-puree-based-drink | 1 |
| 300 | minidrink | 5 |
| 301 | control-task | 2 |
| 302 | 2-d·wk | 1 |
| 303 | 0.25-mmol/l | 1 |
| 304 | 50-nmol/l | 1 |
| 305 | dye-al | 1 |
| 306 | naturalistic-empirical | 1 |
| 307 | 2-nodal | 1 |
| 308 | 3-nodal | 2 |
| 309 | 2-meal | 1 |
| 310 | blow-fill-seal | 1 |
| 311 | microvitreoretinal | 1 |
| 312 | 3-diensional | 1 |
| 313 | self-motivational | 1 |
| 314 | 3-dimenstional | 1 |
| 315 | mini-goal | 1 |
| 316 | 3-dimensinoal | 1 |
| 317 | ceramic-on-metal | 1 |
| 318 | pseudo-experimental | 1 |
| 319 | mannitol-trehalose-nacl | 1 |
| 320 | fh···ch₂cl | 1 |
| 321 | 0.07-g/dl | 1 |
| 322 | 31-mg/dl | 1 |
| 323 | no-observed-effect-level | 1 |
| 324 | laddermill | 3 |
| 325 | 0.05-ml | 1 |
| 326 | 217-ml | 1 |
| 327 | treated-per-protocol | 1 |
| 328 | 0.14±0.0c-molc-mol | 1 |
| 329 | cannabidiol/delta-9-tetrahydrocannabinol | 1 |
| 330 | 4-dibenzocyclooctynol | 1 |
| 331 | hexamidine-chlorhexidine-chlorocresol | 1 |
| 332 | glycosyl-phosphatidylinositol | 1 |
| 333 | maleimidopropionyl | 1 |
| 334 | 1000-mg·l | 1 |
| 335 | 5'-m | 1 |
| 336 | 0.32-g/m | 1 |
| 337 | bmi⩾30kg/m | 1 |
| 338 | bmi≥40kg/m | 1 |
| 339 | 25.3-ml/m | 1 |
| 340 | 0.43-ml/m | 1 |
| 341 | tool-team | 2 |
| 342 | spirogram | 2 |
| 343 | 25-cm | 4 |
| 344 | 4.6-cm | 1 |
| 345 | 2.7-cm | 1 |
| 346 | 107-item | 2 |
| 347 | gastro-intestinal-transport-system | 1 |
| 348 | maize-ecosystem | 1 |
| 349 | servosystem | 1 |
| 350 | 25-cell/mm | 1 |
| 351 | 128.8mm | 1 |
| 352 | 2-degree-of-freedom | 1 |
| 353 | rhinotherm | 4 |
| 354 | metaorganism | 1 |
| 355 | micronailtm | 1 |
| 356 | chlorotriisopropoxytitanium | 1 |
| 357 | chlorhexidine-benzalkonium | 1 |
| 358 | tetra-ethyl-ammonium | 1 |
| 359 | carbonum | 1 |
| 360 | 10-centimorgan | 1 |
| 361 | chinayuan | 1 |
| 362 | formula-driven | 1 |
| 363 | 6-domain | 1 |
| 364 | average-pain | 3 |
| 365 | double-strain | 1 |
| 366 | 5'-fluorescein | 1 |
| 367 | high-normal-protein | 1 |
| 368 | metalloprotein | 2 |
| 369 | low-genistein | 1 |
| 370 | beta-lactamin | 2 |
| 371 | ticagrelor-aspirin | 1 |
| 372 | tetraphenylporphyrin | 1 |
| 373 | single-column | 4 |
| 374 | fac-znn | 1 |
| 375 | non-chlorofluorocarbon | 1 |
| 376 | nucleon-nucleon | 1 |
| 377 | gifford-mcmahon | 1 |
| 378 | direct-immersion | 1 |
| 379 | present-on-admission | 1 |
| 380 | small-group-discussion | 1 |
| 381 | subdiffusion | 1 |
| 382 | bolus-plus-continuous-infusion | 1 |
| 383 | dissolution/permeation | 1 |
| 384 | digital-image-correlation | 1 |
| 385 | data-abstraction | 2 |
| 386 | units/injection | 1 |
| 387 | gradual-weight-reduction | 1 |
| 388 | four-condition | 1 |
| 389 | brief-alcohol-intervention | 1 |
| 390 | form-from-motion | 1 |
| 391 | trypsin-solution | 1 |
| 392 | three-centre-four-electron | 1 |
| 393 | teca/co | 1 |
| 394 | liclo | 1 |
| 395 | ktiopo | 1 |
| 396 | trpo | 1 |
| 397 | co/cso | 1 |
| 398 | thy1.2-ip | 1 |
| 399 | questionnaire-trip | 1 |
| 400 | 1536-snp | 1 |
| 401 | side-hop | 1 |
| 402 | fkrp | 1 |
| 403 | nurse-facilitated-cognitive-group | 1 |
| 404 | morning-training-group | 1 |
| 405 | normal-training-group | 1 |
| 406 | tapering-group | 1 |
| 407 | six-group | 1 |
| 408 | questionnaire/itaq | 1 |
| 409 | fruitbar | 1 |
| 410 | sixteen-year | 1 |
| 411 | bakreshwar | 1 |
| 412 | psa-cr | 6 |
| 413 | radio-over-fiber | 1 |
| 414 | questionnaire-cancer | 1 |
| 415 | trader | 1 |
| 416 | cycloaddition-retro-diels-alder | 1 |
| 417 | ettinger | 2 |
| 418 | father/stepfather | 1 |
| 419 | defries-fulker | 1 |
| 420 | faith-healer | 1 |
| 421 | disk-haler | 1 |
| 422 | thermalcycler | 1 |
| 423 | screener | 92 |
| 424 | 10volt/meter | 1 |
| 425 | colorimeter | 19 |
| 426 | goniometer | 58 |
| 427 | chromometer | 4 |
| 428 | sudorometer | 2 |
| 429 | filter-rectify-filter | 1 |
| 430 | polythioester | 1 |
| 431 | semitendinosus-gracilis-polyester | 1 |
| 432 | widow/widower | 1 |
| 433 | questionnair | 1 |
| 434 | 925-base-pair | 1 |
| 435 | non-cmr | 1 |
| 436 | cognition-behavior | 1 |
| 437 | piezosensor | 1 |
| 438 | desiccator | 4 |
| 439 | reporter-interpreter-manager-educator | 1 |
| 440 | burststimulator | 1 |
| 441 | co-actor | 1 |
| 442 | proton-pump-inhibitor | 1 |
| 443 | non-ipr | 1 |
| 444 | measure-diabetes | 1 |
| 445 | no-yes | 1 |
| 446 | tungsten/bis | 1 |
| 447 | triple-plateletpheresis | 1 |
| 448 | 1-o-alkyl-2,3-diacyl-sn-glycerols | 1 |
| 449 | dd-ms | 1 |
| 450 | nacos | 1 |
| 451 | reductase-inhibitors | 1 |
| 452 | breatlessness | 1 |
| 453 | finite-elements | 1 |
| 454 | multi-measurements | 1 |
| 455 | ldh/pts | 1 |
| 456 | streptotoccus | 1 |
| 457 | tearscope-plus | 1 |
| 458 | p.tyr278cys | 1 |
| 459 | phospho-t | 1 |
| 460 | tetratricopeptide-repeat | 1 |
| 461 | variable-number-tandem-repeat | 1 |
| 462 | hfhs-high-fat | 1 |
| 463 | summary/abstract | 1 |
| 464 | dtdt | 1 |
| 465 | minusheet | 1 |
| 466 | high-calorie/high-fat-diet | 1 |
| 467 | no-jacket | 1 |
| 468 | bnet | 1 |
| 469 | u-graft | 1 |
| 470 | weight-average-molecular-weight | 1 |
| 471 | quadrupole-quadrupole-time-of-flight | 1 |
| 472 | 2-trait | 1 |
| 473 | 1.8-unit | 1 |
| 474 | usual-salt | 1 |
| 475 | module-adult | 1 |
| 476 | chylomicron-remnant | 1 |
| 477 | multidrug-tolerant | 1 |
| 478 | cross-reactant | 1 |
| 479 | 20-edent | 1 |
| 480 | profile-edent | 1 |
| 481 | disease-independent | 1 |
| 482 | inventory-student | 2 |
| 483 | pseudobivalent | 2 |
| 484 | pharmaceutical-equivalent | 1 |
| 485 | 9-segment | 1 |
| 486 | categories-enjoyment | 1 |
| 487 | pcwallstent | 1 |
| 488 | heptafluoropropyl-substituent | 1 |
| 489 | 12.01-point | 1 |
| 490 | 9.2-point | 1 |
| 491 | 15.3-point | 1 |
| 492 | 5.4-point | 1 |
| 493 | 16.5-point | 1 |
| 494 | 2.05-point | 1 |
| 495 | 11.9-point | 1 |
| 496 | post-critical-point | 1 |
| 497 | stress-test | 2 |
| 498 | nversusu-test | 1 |
| 499 | probiotic/test | 1 |
| 500 | lisa-nut | 1 |
| 501 | sert-knockout | 1 |
| 502 | n-cu | 1 |
| 503 | cu/cu | 1 |
| 504 | qiandu | 1 |
| 505 | usv | 1 |
| 506 | regular-chow | 1 |
| 507 | postal/fax | 1 |
| 508 | low-glycaemic-index | 1 |
| 509 | reliable-change-index | 1 |
| 510 | bric-a-brac/tram-track/broad-complex | 1 |
| 511 | protease-inhibitor-modulating-matrix | 1 |
| 512 | starch-matrix | 1 |
| 513 | vesico-ureteral-reflux | 1 |
| 514 | 152-day | 1 |
| 515 | 0.8-day | 1 |
| 516 | ≥12/day | 1 |
| 517 | ≥6/day | 1 |
| 518 | tissue-micro-array | 1 |
| 519 | fluoroenzymeimmunoassay | 1 |
| 520 | structural-study | 1 |
| 521 | pharmaco-epidemiology | 1 |
| 522 | gastrointestinal/hepatology | 1 |
| 523 | no-energy | 1 |
| 524 | mutely | 1 |
| 525 | tcm-only | 1 |
| 526 | sirna/poly | 1 |
| 527 | ministernotomy | 2 |
| 528 | monothera-py | 1 |
| 529 | recollect/know/no-memory | 1 |
| 530 | detection/confirmatory | 1 |
| 531 | case-history | 1 |
| 532 | four-country | 4 |
| 533 | long-term-care-facility | 1 |
| 534 | hypermucoviscosity | 1 |
| 535 | micro-cavity | 1 |
| 536 | mismatch-negativity | 1 |
| 537 | quiz | 98 |
| 538 | c-h∙∙∙π | 1 |
| 539 | sunfire™ | 1 |
| 540 | turbuhaler™ | 2 |
| 541 | test™ | 4 |
| 542 | control® | 1 |
| 543 | 3-keto-5α-steroid-δ | 1 |
| 544 | μ1-η | 1 |